C Schmid
Benefit ofF-fluorocholine PET imaging in parathyroid surgery
Huber G, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann P, von Schulthess G. Benefit ofF-fluorocholine PET imaging in parathyroid surgery. Eur Radiol 2018
Jan 25, 2018Benefit ofF-fluorocholine PET imaging in parathyroid surgery
Jan 25, 2018Eur Radiol 2018
Huber Gerhard, Hüllner M, Schmid C, Brunner A, Sah B, Vetter D, Kaufmann P A, von Schulthess G K
[Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?]
Meerwein C, Vital D, Greutmann M, Schmid C, Huber G. [Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?]. HNO 2014; 62:100-5.
Feb 1, 2014[Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?]
Feb 1, 2014HNO 2014; 62:100-5
Meerwein C, Vital D, Greutmann M, Schmid C, Huber Gerhard
Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Köhler S, Tschopp O, Sze L, Neidert M, Bernays R, Spanaus K, Wiesli P, Schmid C. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?. Gen Comp Endocrinol 2013; 188:282-7.
May 4, 2013Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
May 4, 2013Gen Comp Endocrinol 2013; 188:282-7
Köhler S, Tschopp O, Sze Lisa, Neidert M, Bernays R-L, Spanaus K-S, Wiesli P, Schmid C
Excessively high soluble Klotho in patients with acromegaly
Sze L, Bernays R, Zwimpfer C, Wiesli P, Brändle M, Schmid C. Excessively high soluble Klotho in patients with acromegaly. J Intern Med 2012; 272:93-7.
Apr 23, 2012Excessively high soluble Klotho in patients with acromegaly
Apr 23, 2012J Intern Med 2012; 272:93-7
Sze Lisa, Bernays R L, Zwimpfer C, Wiesli P, Brändle Michael, Schmid C
[Tiredness, hyperpigmentation, weight loss, nausea and vomiting. Polyglandular autoimmune syndrome (PAS) type 2]
Locher R, Köhler S, Schwanda S, Schmid C. [Tiredness, hyperpigmentation, weight loss, nausea and vomiting. Polyglandular autoimmune syndrome (PAS) type 2]. Praxis (Bern 1994) 2010; 99:1223-8.
Oct 6, 2010[Tiredness, hyperpigmentation, weight loss, nausea and vomiting. Polyglandular autoimmune syndrome (PAS) type 2]
Oct 6, 2010Praxis (Bern 1994) 2010; 99:1223-8
Locher Rebecca, Köhler S, Schwanda S, Schmid C
A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Wiesli P, Brändle M, Schwegler B, Lehmann R, Spinas G, Schmid C. A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. Journal of internal medicine 2002; 252:504-9.
Dec 1, 2002A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Dec 1, 2002Journal of internal medicine 2002; 252:504-9
Wiesli P, Brändle Michael, Schwegler B, Lehmann R, Spinas G A, Schmid C
Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
Brändle M, Pfammatter T, Spinas G, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clinical endocrinology 2001; 55:357-62.
Sep 1, 2001Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
Sep 1, 2001Clinical endocrinology 2001; 55:357-62
Brändle Michael, Pfammatter T, Spinas G A, Lehmann R, Schmid C
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
Brändle M, Lehmann R, Maly F, Schmid C, Spinas G. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes care 2001; 24:1253-8.
Jul 1, 2001Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
Jul 1, 2001Diabetes care 2001; 24:1253-8
Brändle Michael, Lehmann R, Maly F E, Schmid C, Spinas G A
10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
Clerici T, Schmid C, Komminoth P, Lange J, Spinas G, Brändle M. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6.
Jun 30, 200110 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
Jun 30, 2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6
Clerici Thomas, Schmid C, Komminoth P, Lange Jochen, Spinas G A, Brändle Michael
[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Brändle M, Schlaeppi M, Schmid C. [Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]. Schweiz Med Wochenschr 2000; 130:861.
Jun 3, 2000[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Jun 3, 2000Schweiz Med Wochenschr 2000; 130:861
Brändle Michael, Schlaeppi Marc, Schmid C
Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor
Schoch O, Speich R, Schmid C, Tschopp O, Russi E, Weder W, Boehler A. Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor. Transplantation 2000; 69:1629-32.
Apr 27, 2000Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor
Apr 27, 2000Transplantation 2000; 69:1629-32
Schoch Otto, Speich R, Schmid C, Tschopp O, Russi E W, Weder W, Boehler A
Galactorrhoea and pituitary mass: a typical prolactinoma?
Brändle M, Schmid C. Galactorrhoea and pituitary mass: a typical prolactinoma?. Postgraduate medical journal 2000; 76:232-4.
Apr 1, 2000Galactorrhoea and pituitary mass: a typical prolactinoma?
Apr 1, 2000Postgraduate medical journal 2000; 76:232-4
Brändle Michael, Schmid C
[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
Eggenberger C, Brändle M, Galeazzi R, Spinas G, Schmid C. [Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]. Schweizerische medizinische Wochenschrift 1999; 129:890-5.
Jun 12, 1999[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
Jun 12, 1999Schweizerische medizinische Wochenschrift 1999; 129:890-5
Eggenberger C, Brändle Michael, Galeazzi R L, Spinas G A, Schmid C
Medullary thyroid carcinoma in Graves' disease
Brändle M, Galeazzi R, Diener P, Schmid C. Medullary thyroid carcinoma in Graves' disease. Clinical endocrinology 1999; 50:545-6.
Apr 1, 1999Medullary thyroid carcinoma in Graves' disease
Apr 1, 1999Clinical endocrinology 1999; 50:545-6
Brändle Michael, Galeazzi R L, Diener Pierre-André, Schmid C
Relapsing Whipple's disease presenting with hypopituitarism
Brändle M, Ammann P, Spinas G, Dutly F, Galeazzi R, Schmid C, Altwegg M. Relapsing Whipple's disease presenting with hypopituitarism. Clinical endocrinology 1999; 50:399-403.
Mar 1, 1999Relapsing Whipple's disease presenting with hypopituitarism
Mar 1, 1999Clinical endocrinology 1999; 50:399-403
Brändle M, Ammann Peter, Spinas G A, Dutly F, Galeazzi R L, Schmid C, Altwegg M